A multifactorial analysis revealed that lower baseline CD8 counts were associated with an increased risk of a second tumor in CLL/SLL patients [24], reinforcing that impaired immune surveillance is an important risk factor for MPMNs. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.